Systemic alterations in the metabolome of diabetic NOD mice delineate increased oxidative stress accompanied by reduced inflammation and hypertriglyceremia.
暂无分享,去创建一个
Oliver Fiehn | Dmitry Grapov | Manami Hara | Johannes Fahrmann | O. Fiehn | G. Bell | M. Hara | Jun Yang | B. Hammock | J. Fahrmann | Dmitry Grapov | Graeme I Bell | Jun Yang | Bruce Hammock | D. Grapov
[1] O. Fiehn,et al. Diabetes associated metabolomic perturbations in NOD mice , 2014, Metabolomics.
[2] M. Bajaj,et al. The regulation of muscle protein turnover in diabetes. , 2013, The international journal of biochemistry & cell biology.
[3] J. Ilonen,et al. Cord Serum Lipidome in Prediction of Islet Autoimmunity and Type 1 Diabetes , 2013, Diabetes.
[4] B. Hammock,et al. Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men. , 2013, Prostaglandins, leukotrienes, and essential fatty acids.
[5] Oliver Fiehn,et al. LipidBlast - in-silico tandem mass spectrometry database for lipid identification , 2013, Nature Methods.
[6] F. Crea,et al. Adaptive Immunity, Inflammation, and Cardiovascular Complications in Type 1 and Type 2 Diabetes Mellitus , 2013, Journal of diabetes research.
[7] U. Das. Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules. , 2013, Prostaglandins, leukotrienes, and essential fatty acids.
[8] Dyanne P Westerberg,et al. Diabetic ketoacidosis: evaluation and treatment. , 2013, American family physician.
[9] K. Hamazaki,et al. Prostaglandins, Leukotrienes and Essential Fatty Acids , 2013 .
[10] Cheol-Young Park,et al. 1,5-Anhydroglucitol in diabetes mellitus , 2013, Endocrine.
[11] Nele Friedrich,et al. Metabolomics in diabetes research. , 2012, The Journal of endocrinology.
[12] R. Robertson,et al. Cyclooxygenase-2, Not Microsomal Prostaglandin E Synthase-1, Is the Mechanism for Interleukin-1β-induced Prostaglandin E2 Production and Inhibition of Insulin Secretion in Pancreatic Islets* , 2012, The Journal of Biological Chemistry.
[13] B. Boehm,et al. Anti-Inflammatory Therapy in Type 1 Diabetes , 2012, Current Diabetes Reports.
[14] R. Flavell,et al. Pancreatic islet expression of chemokine CCL2 suppresses autoimmune diabetes via tolerogenic CD11c+ CD11b+ dendritic cells , 2012, Proceedings of the National Academy of Sciences.
[15] J. Mohamed,et al. The role of oxidative stress and antioxidants in diabetic complications. , 2012, Sultan Qaboos University medical journal.
[16] M. Kanehisa,et al. The KEGG databases and tools facilitating omics analysis: latest developments involving human diseases and pharmaceuticals. , 2012, Methods in molecular biology.
[17] Oliver Fiehn,et al. MetaMapp: mapping and visualizing metabolomic data by integrating information from biochemical pathways and chemical and mass spectral similarity , 2012, BMC Bioinformatics.
[18] E. Bonifacio,et al. Age- and Islet Autoimmunity–Associated Differences in Amino Acid and Lipid Metabolites in Children at Risk for Type 1 Diabetes , 2011, Diabetes.
[19] Matej Oresic,et al. Metabolic Regulation in Progression to Autoimmune Diabetes , 2011, PLoS Comput. Biol..
[20] P. Luo,et al. Eicosanoids, β-cell function, and diabetes. , 2011, Prostaglandins & other lipid mediators.
[21] K. Nieman,et al. Insulin administration abrogates perturbation of methyl group and homocysteine metabolism in streptozotocin-treated type 1 diabetic rats. , 2011, American journal of physiology. Endocrinology and metabolism.
[22] G. Smyth,et al. Statistical Applications in Genetics and Molecular Biology Permutation P -values Should Never Be Zero: Calculating Exact P -values When Permutations Are Randomly Drawn , 2011 .
[23] K. Nair,et al. Protein and energy metabolism in type 1 diabetes. , 2010, Clinical nutrition.
[24] K. Park,et al. Lysophosphatidylcholine Activates Adipocyte Glucose Uptake and Lowers Blood Glucose Levels in Murine Models of Diabetes* , 2009, The Journal of Biological Chemistry.
[25] Jun Yang,et al. Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry. , 2009, Analytical chemistry.
[26] Giuseppe Palermo,et al. Performance of PLS regression coefficients in selecting variables for each response of a multivariate PLS for omics-type data , 2009, Advances and applications in bioinformatics and chemistry : AABC.
[27] Robert Castelo,et al. Reverse Engineering Molecular Regulatory Networks from Microarray Data with qp-Graphs , 2009, J. Comput. Biol..
[28] S. Eckhardt,et al. Clinical Applications of Metabolomics in Oncology: A Review , 2009, Clinical Cancer Research.
[29] Olli Simell,et al. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes , 2008, The Journal of experimental medicine.
[30] Tao Jiang,et al. ChemmineR: a compound mining framework for R , 2008, Bioinform..
[31] A. Shevchenko,et al. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. , 2008, Journal of lipid research.
[32] Oliver Fiehn,et al. Extending the breadth of metabolite profiling by gas chromatography coupled to mass spectrometry. , 2008, Trends in analytical chemistry : TRAC.
[33] Oliver Fiehn,et al. Quality control for plant metabolomics: reporting MSI-compliant studies. , 2008, The Plant journal : for cell and molecular biology.
[34] U. Edlund,et al. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. , 2008, Analytical chemistry.
[35] Yanli Wang,et al. PubChem: Integrated Platform of Small Molecules and Biological Activities , 2008 .
[36] Oliver Fiehn,et al. A comprehensive urinary metabolomic approach for identifying kidney cancerr. , 2007, Analytical biochemistry.
[37] Martin Scholz,et al. Pacific Symposium on Biocomputing 12:169-180(2007) SETUP X – A PUBLIC STUDY DESIGN DATABASE FOR METABOLOMIC PROJECTS , 2022 .
[38] K. Nair,et al. Effects of insulin deprivation and treatment on homocysteine metabolism in people with type 1 diabetes. , 2006, The Journal of clinical endocrinology and metabolism.
[39] J. McGill,et al. Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus. , 2006, Journal of the American College of Cardiology.
[40] Martin Scholz,et al. Setup and Annotation of Metabolomic Experiments by Integrating Biological and Mass Spectrometric Metadata , 2005, DILS.
[41] J. Nadler,et al. Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity , 2005, Diabetologia.
[42] H. Matsushime,et al. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. , 2005, Biochemical and biophysical research communications.
[43] H. Drexhage,et al. NOD mice have a severly impaired ability to recruit leukocytes into sites of inflammation , 2005, European journal of immunology.
[44] N. Mauras,et al. Evidence for accelerated rates of glutathione utilization and glutathione depletion in adolescents with poorly controlled type 1 diabetes. , 2005, Diabetes.
[45] J. Corbett,et al. Role of Cyclooxygenase-2 in Cytokine-induced β-Cell Dysfunction and Damage by Isolated Rat and Human Islets* , 2004, Journal of Biological Chemistry.
[46] P. Newsholme,et al. Arachidonic acid, palmitic acid and glucose are important for the modulation of clonal pancreatic beta-cell insulin secretion, growth and functional integrity. , 2004, Clinical science.
[47] O. Fiehn,et al. Process for the integrated extraction, identification and quantification of metabolites, proteins and RNA to reveal their co‐regulation in biochemical networks , 2004, Proteomics.
[48] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[49] J. Reusch,et al. Diabetes, microvascular complications, and cardiovascular complications: what is it about glucose? , 2003, The Journal of clinical investigation.
[50] M. Donath,et al. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. , 2003, Diabetes.
[51] R. Robertson,et al. Inhibition of Interleukin-1β-Induced COX-2 and EP3 Gene Expression by Sodium Salicylate Enhances Pancreatic Islet β-Cell Function , 2002 .
[52] J. Macgregor,et al. An investigation of orthogonal signal correction algorithms and their characteristics , 2002 .
[53] R. Robertson,et al. Inhibition of interleukin-1beta-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet beta-cell function. , 2002, Diabetes.
[54] I. Goldberg. Diabetic Dyslipidemia: Causes and Consequences , 2001 .
[55] I. Goldberg,et al. Clinical review 124: Diabetic dyslipidemia: causes and consequences. , 2001, The Journal of clinical endocrinology and metabolism.
[56] J. McGarry,et al. A fatty acid- dependent step is critically important for both glucose- and non-glucose-stimulated insulin secretion. , 1998, The Journal of clinical investigation.
[57] J. Cunningham. The glucose/insulin system and vitamin C: implications in insulin-dependent diabetes mellitus. , 1998, Journal of the American College of Nutrition.
[58] M. Dominiczak,et al. The effect of delta-gluconolactone, an oxidised analogue of glucose, on the nonenzymatic glycation of human and rat haemoglobin. , 1997, Clinica chimica acta; international journal of clinical chemistry.
[59] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[60] W. Guder,et al. Carbohydrate and lipid metabolism of the renal tubule in diabetes mellitus. , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[61] F. Dunn. Management of hyperlipidemia in diabetes mellitus. , 1992, Endocrinology and metabolism clinics of North America.
[62] R. Hughes,et al. A relationship between ascorbic acid and threonic acid in guinea-pigs. , 1983, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.